Cargando…
Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment
BACKGROUND: High grade primary bone sarcomas are rare cancers that affect mostly children and young adults. Osteosarcoma and Ewing sarcoma are the most common histological subtypes in this age group, with current multimodality treatment strategies achieving 55-70% overall survival. As there remains...
Autores principales: | van Maldegem, Annemiek M, Bhosale, Aparna, Gelderblom, Hans J, Hogendoorn, Pancras CW, Hassan, Andrew B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351714/ https://www.ncbi.nlm.nih.gov/pubmed/22587841 http://dx.doi.org/10.1186/2045-3329-2-5 |
Ejemplares similares
-
The clinical use of biomarkers as prognostic factors in Ewing sarcoma
por: van Maldegem, Annmeik M, et al.
Publicado: (2012) -
Introducing fluorescence guided surgery into orthopedic oncology: A systematic review of candidate protein targets for Ewing sarcoma
por: Bosma, Sarah E, et al.
Publicado: (2018) -
Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes
por: Sand, Laurens G. L., et al.
Publicado: (2015) -
Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013
por: van Maldegem, Annemiek M, et al.
Publicado: (2014) -
Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy
por: Sand, Laurens G. L., et al.
Publicado: (2016)